Healthcare provider profile · identity verified

Danielle Suzanne Mcdonald, DO

Family Practice · BRUSH, CO · NPI 1932461506

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	192	35
Metformin Hcl	Metformin Hcl	142	23
Atorvastatin Calcium	Atorvastatin Calcium	116	27
Gabapentin	Gabapentin	116	26
Losartan Potassium	Losartan Potassium	111	25
Omeprazole	Omeprazole	109	18
Lisinopril	Lisinopril	99	27
Alendronate Sodium	Alendronate Sodium	75	12
Pregabalin	Pregabalin	72	11
Albuterol Sulfate Hfa	Albuterol Sulfate	71	18
Sertraline Hcl	Sertraline Hcl	61	12
Jardiance	Empagliflozin	60	suppressed
Trazodone Hcl	Trazodone Hcl	59	12
Amlodipine Besylate	Amlodipine Besylate	58	16
Januvia	Sitagliptin Phosphate	55	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	55	17
Oxybutynin Chloride Er	Oxybutynin Chloride	54	12
Eliquis	Apixaban	52	suppressed
Simvastatin	Simvastatin	52	12
Hydrochlorothiazide	Hydrochlorothiazide	51	15
Furosemide	Furosemide	46	16
Metoprolol Tartrate	Metoprolol Tartrate	41	suppressed
Pantoprazole Sodium	Pantoprazole Sodium	40	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	37	11
Baclofen	Baclofen	36	suppressed
Famotidine	Famotidine	36	suppressed
Oxycodone Hcl	Oxycodone Hcl	36	suppressed
Ropinirole Hcl	Ropinirole Hcl	35	suppressed
Meloxicam	Meloxicam	34	17
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	32	suppressed
Bumetanide	Bumetanide	29	suppressed
Mirtazapine	Mirtazapine	29	suppressed
Prednisone	Prednisone	28	15
Duloxetine Hcl	Duloxetine Hcl	26	suppressed
Propranolol Hcl	Propranolol Hcl	26	suppressed
Bupropion Xl	Bupropion Hcl	24	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	24	suppressed
Tramadol Hcl	Tramadol Hcl	24	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	23	suppressed
Fluticasone Propionate	Fluticasone Propionate	23	suppressed
Carvedilol	Carvedilol	22	suppressed
Aripiprazole	Aripiprazole	21	suppressed
Chlorthalidone	Chlorthalidone	21	suppressed
Clopidogrel	Clopidogrel Bisulfate	21	suppressed
Mounjaro	Tirzepatide	21	suppressed
Ozempic	Semaglutide	19	suppressed
Citalopram Hbr	Citalopram Hydrobromide	18	suppressed
Combivent Respimat	Ipratropium/Albuterol Sulfate	18	suppressed
Ezetimibe	Ezetimibe	18	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	18	suppressed
Lorazepam	Lorazepam	18	suppressed
Metformin Hcl Er	Metformin Hcl	18	suppressed
Metronidazole	Metronidazole	18	suppressed
Phenobarbital	Phenobarbital	18	suppressed
Promethazine Hcl	Promethazine Hcl	18	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	17	suppressed
Pravastatin Sodium	Pravastatin Sodium	17	suppressed
Allopurinol	Allopurinol	16	suppressed
Metoprolol Succinate	Metoprolol Succinate	16	suppressed
Trulicity	Dulaglutide	16	suppressed
Benazepril Hcl	Benazepril Hcl	15	suppressed
Ulticare Pen Needle	Pen Needle, Diabetic	15	suppressed
Xarelto	Rivaroxaban	14	suppressed
Celecoxib	Celecoxib	13	suppressed
Cephalexin	Cephalexin	13	11
Divalproex Sodium Er	Divalproex Sodium	13	suppressed
Glipizide Er	Glipizide	13	suppressed
Primidone	Primidone	13	suppressed
Repaglinide	Repaglinide	13	suppressed
Spiriva Handihaler	Tiotropium Bromide	13	suppressed
Spironolactone	Spironolactone	13	suppressed
Warfarin Sodium	Warfarin Sodium	13	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	12	suppressed
Arnuity Ellipta	Fluticasone Furoate	12	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	12	suppressed
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Incruse Ellipta	Umeclidinium Bromide	12	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	12	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	12	suppressed
Sucralfate	Sucralfate	12	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	11	suppressed
Varenicline Tartrate	Varenicline Tartrate	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error